Granahan Investment Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Granahan Investment Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-27,775	Closed	-$560K	–	203
2021 Q3	$560K	Sell	27,775 -173,737	-86%	-$4.8M	0.01%	189
2021 Q2	$7.52M	Buy	+201,512	New	+$6.18M	0.14%	134

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Granahan Investment Management's DRNA Position: Q4 2021 in Review

Granahan Investment Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 27,775 shares — an estimated $560K sold.

Granahan Investment Management first reported a position in DRNA in Q2 2021 and held it in 2 quarters. The position peaked at $7.52M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Granahan Investment Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Granahan Investment Management sold 27,775 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $560K.
Granahan Investment Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
Granahan Investment Management's Dicerna Pharmaceuticals, Inc. position peaked at $7.52M in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Granahan Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.